111 related articles for article (PubMed ID: 7503797)
1. Proton release from HeLa cells and alkalization of cytoplasm induced by diferric transferrin or ferricyanide and its inhibition by the diarylsulfonylurea antitumor drug N-(4-methylphenylsulfonyl)-N'-(4-cholorophenyl) urea (LY181984).
Sun E; Lawrence J; Morré DM; Sun I; Crane FL; MacKellar WC; Morré DJ
Biochem Pharmacol; 1995 Oct; 50(9):1461-8. PubMed ID: 7503797
[TBL] [Abstract][Full Text] [Related]
2. The antitumor sulfonylurea N-(4-methylphenylsulfonyl)-N'-(4-chlorophenyl) urea (LY181984) inhibits NADH oxidase activity of HeLa plasma membranes.
Morré DJ; Wu LY; Morré DM
Biochim Biophys Acta; 1995 Nov; 1240(1):11-7. PubMed ID: 7495842
[TBL] [Abstract][Full Text] [Related]
3. NADH oxidase activity of HeLa plasma membranes inhibited by the antitumor sulfonylurea N-(4-methylphenylsulfonyl)-N'-(4-chlorophenyl) urea (LY181984) at an external site.
Morré DJ
Biochim Biophys Acta; 1995 Dec; 1240(2):201-8. PubMed ID: 8541291
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of NADH oxidase activity and growth of HeLa cells by the antitumor sulfonylurea, N-(4-methylphenylsulfonyl)-N'-(4-chlorophenyl) urea (LY181984) and response to epidermal growth factor.
Morré DJ; Wu LY; Morré DM
Biochim Biophys Acta; 1997 Feb; 1355(2):114-20. PubMed ID: 9042331
[TBL] [Abstract][Full Text] [Related]
5. Diferric transferrin reduction stimulates the Na+/H+ antiport of HeLa cells.
Sun IL; Garcia-Cañero R; Liu W; Toole-Simms W; Crane FL; Morré DJ; Löw H
Biochem Biophys Res Commun; 1987 May; 145(1):467-73. PubMed ID: 3036130
[TBL] [Abstract][Full Text] [Related]
6. Response of a cell-surface NADH oxidase to the antitumor sulfonylurea N-(4-methylphenylsulfonyl)-N'-(4-chlorophenylurea) (LY181984) modulated by redox.
Morré DJ; Wu LY; Morré DM
Biochim Biophys Acta; 1998 Mar; 1369(2):185-92. PubMed ID: 9518604
[TBL] [Abstract][Full Text] [Related]
7. A circulating form of NADH oxidase activity responsive to the antitumor sulfonylurea N-4-(methylphenylsulfonyl)-N'-(4-chlorophenyl)urea (LY181984) specific to sera from cancer patients.
Morré DJ; Reust T
J Bioenerg Biomembr; 1997 Jun; 29(3):281-9. PubMed ID: 9298713
[TBL] [Abstract][Full Text] [Related]
8. A protein disulfide-thiol interchange activity of HeLa plasma membranes inhibited by the antitumor sulfonylurea N-(4-methylphenylsulfonyl)-N'-(4-chlorophenyl) urea (LY181984).
Morré DJ; Jacobs E; Sweeting M; de Cabo R; Morré DM
Biochim Biophys Acta; 1997 Apr; 1325(1):117-25. PubMed ID: 9106489
[TBL] [Abstract][Full Text] [Related]
9. Antitumor sulfonylurea-inhibited NADH oxidase of cultured HeLa cells shed into media.
Morré DJ; Wilkinson FE; Kim C; Cho N; Lawrence J; Morré DM; McClure D
Biochim Biophys Acta; 1996 Apr; 1280(2):197-206. PubMed ID: 8639694
[TBL] [Abstract][Full Text] [Related]
10. Reduction of diferric transferrin by SV40 transformed pineal cells stimulates Na+/H+ antiport activity.
Sun IL; Toole-Simms W; Crane FL; Morré DJ; Löw H; Chou JY
Biochim Biophys Acta; 1988 Feb; 938(1):17-23. PubMed ID: 2827775
[TBL] [Abstract][Full Text] [Related]
11. Transplasma membrane electron and proton transport is inhibited by chloroquine.
Toole-Simms W; Sun IL; Morré DJ; Crane FL
Biochem Int; 1990; 21(4):761-9. PubMed ID: 2173587
[TBL] [Abstract][Full Text] [Related]
12. Identification of antitumor sulfonylurea binding proteins of HeLa plasma membranes.
Morré DJ; Wilkinson FE; Lawrence J; Cho N; Paulik M
Biochim Biophys Acta; 1995 Jun; 1236(2):237-43. PubMed ID: 7794962
[TBL] [Abstract][Full Text] [Related]
13. Decrease of NADH in HeLa cells in the presence of transferrin or ferricyanide.
Navas P; Sun IL; Morré DJ; Crane FL
Biochem Biophys Res Commun; 1986 Feb; 135(1):110-5. PubMed ID: 3954760
[TBL] [Abstract][Full Text] [Related]
14. Na+/H+ exchange and aggregation of human platelets activated by ADP: the exchange is not required for aggregation.
Funder J; Hershco L; Rothstein A; Livne A
Biochim Biophys Acta; 1988 Mar; 938(3):425-33. PubMed ID: 2831980
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of PAIII rat prostatic adenocarcinoma growth and metastasis by a new diarylsulfonylurea antitumor agent, LY181984.
Neubauer BL; Merriman RL; Best KL; Goode RL; Sarosdy MF; Tanzer LR; Howbert JJ
J Urol; 1992 Feb; 147(2):500-4. PubMed ID: 1732631
[TBL] [Abstract][Full Text] [Related]
16. Evidence for mitochondrial localization of N-(4-methylphenylsulfonyl)-N'-(4-chlorophenyl)urea in human colon adenocarcinoma cells.
Houghton PJ; Bailey FC; Houghton JA; Murti KG; Howbert JJ; Grindey GB
Cancer Res; 1990 Feb; 50(3):664-8. PubMed ID: 2297707
[TBL] [Abstract][Full Text] [Related]
17. HeLa plasma membranes bind the antitumor sulfonylurea LY181984 with high affinity.
Morré DJ; Morré DM; Stevenson J; MacKellar W; McClure D
Biochim Biophys Acta; 1995 May; 1244(1):133-40. PubMed ID: 7766649
[TBL] [Abstract][Full Text] [Related]
18. Intracellular pH regulation in rainbow trout (Oncorhynchus mykiss) hepatocytes: the activity of sodium/proton exchange is oxygen-dependent.
Tuominen A; Rissanen E; Bogdanova A; Nikinmaa M
J Comp Physiol B; 2003 Jun; 173(4):301-8. PubMed ID: 12820008
[TBL] [Abstract][Full Text] [Related]
19. A pyruvate-proton symport and an H+-ATPase regulate the intracellular pH of Trypanosoma brucei at different stages of its life cycle.
Vanderheyden N; Wong J; Docampo R
Biochem J; 2000 Feb; 346 Pt 1(Pt 1):53-62. PubMed ID: 10657239
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of chemotactic factor-activated Na+/H+ exchange in human neutrophils by analogues of amiloride: structure-activity relationships in the amiloride series.
Simchowitz L; Cragoe EJ
Mol Pharmacol; 1986 Aug; 30(2):112-20. PubMed ID: 3016497
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
